Thermo Fisher Scientific Inc. (TMO)
| Market Cap | 205.40B |
| Revenue (ttm) | 43.21B |
| Net Income (ttm) | 6.58B |
| Shares Out | 377.61M |
| EPS (ttm) | 17.30 |
| PE Ratio | 31.45 |
| Forward PE | 23.20 |
| Dividend | $1.72 (0.32%) |
| Ex-Dividend Date | Sep 15, 2025 |
| Volume | 2,560,056 |
| Open | 540.00 |
| Previous Close | 543.32 |
| Day's Range | 536.46 - 545.86 |
| 52-Week Range | 385.46 - 610.97 |
| Beta | 0.77 |
| Analysts | Buy |
| Price Target | 576.93 (+6.06%) |
| Earnings Date | Oct 22, 2025 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for TMO stock is "Buy." The 12-month stock price target is $576.93, which is an increase of 6.06% from the latest price.
News
Top 15 High-Growth Dividend Stocks For October 2025
The Top 15 High-Growth Dividend Stock list for October 2025 targets a 12% long-term return, despite underperforming SPY and VIG in September. These 15 stocks offer a 1.4% average yield and have grown ...
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub
WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub.
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2025 before ...
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.5 billion aggregate principal amount (the “Offering”) ...
Thermo Fisher Scientific Shares Up 3.3% After Power Inflow Signal
Thermo Fisher Scientific Inc (NYSE:TMO) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutio...
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how...
BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity
TORONTO--(BUSINESS WIRE)--BenchSci today announced a strategic partnership with Thermo Fisher Scientific Inc. to create AI-powered tools to accelerate R&D productivity.
Dr. Park CDMO Selects Thermo Fisher Scientific to Equip New Viral Vector Manufacturing Facility
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr. Park, an emerging viral vector contract development and manufacturing orga...
Thermo Fisher: A Wide-Moat Leader With Multi-Year Growth Ahead
Thermo Fisher is well positioned as a mission-critical partner in life sciences, with a recurring revenue base and strong end-to-end solutions. The company's strategic acquisitions and leadership in b...
Thermo Fisher Scientific Launches the Thermo Scientific Hypulse Surface Analysis System to Accelerate the Understanding of Material Surfaces
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This innovative surface analysis...
Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 finalists in the Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation's premie...
Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, tar...
Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin for Enhanced Bioprocessing Performance
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ Efficient-Pro™ Medium (+) Insulin, a next-generation medium designed to i...
Thermo Fisher Scientific Inc. (TMO) J.P. Morgan CEO Call Series Call (Transcript)
Thermo Fisher Scientific Inc. J.P. Morgan CEO Call Series September 5, 2025 1:00 PM EDT Company Participants Marc Casper - Chairman, President & CEO Conference Call Participants Rachel Vatnsdal Olson ...
Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield, New Jersey Site
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the completion of its acquisition of Sanofi's state-of-the-art sterile f...
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.
Accelerates Solventum's business transformation to deliver long-term shareholder value Net proceeds will be used primarily to pay down debt ST. PAUL, Minn.
Thermo Fisher Scientific Completes Acquisition of Solventum's Purification and Filtration Business
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the completion of its acquisition of the Purification...
Thermo Fisher Scientific to Participate in J.P. Morgan CEO Call Series on September 5, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pa...
Thermo Fisher Scientific Secures R&D 100 Awards for Innovations Accelerating the Discovery and Development of Therapies
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, is proud to receive three R&D 100 Awards for innovations designed to advance scientific discovery i...
mRNA Biotechs - Long-Term Value Risks Abound
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c...
ERMA Systems Welcomes Israel Aker, PharmD, RPh, Thermo Fisher Scientific to Advisory Board to Strengthen Medical Affairs Strategy
MIAMI--(BUSINESS WIRE)--ERMA Systems, the AI-powered SaaS company transforming how Life Sciences organizations manage their Promotional and Medical Review Committee (PRC/MRC) processes, proudly announ...
Thermo Fisher Scientific Opens Manufacturing Center of Excellence Site in North Carolina
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its innovative manufacturing center of excellence facility in ...
Thermo Fisher Positioned As Biopharma's Partner Of Choice
Could Thermo Fisher Scientific Inc. TMO be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strat...
Final Trades: Toast, Transdigm, Thermo Fisher and Amazon
The Investment Committee give you their top stocks to watch for the second half.
Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside
Revenue growth is accelerating, led by pharma/biotech momentum and bioproduction demand. The medium-term margin outlook is positive with cost cuts, AI-driven efficiencies, and lapping of tariff headwi...